It has been a very strange week to be British, but with Britain's departure from the EU, our health could also be impacted. The Health Editor warned that patients were being put at risk as medical devices approved by the EU system were three times more risky than the model used in the US. In particular, they have highlighted that products to treat heart conditions are likely to be recalled or result in a safety alert if they have to go through EU regulations before US approval. The process will be lengthy and cause delays so with our departure from the EU, as a country we'll have to establish new systems to govern the safety of the devices. Although the old model was deemed quicker than in the US "the possible benefits of faster access must be carefully weighed against the risks arising from devices". Along with all the other changes and insecurities we're facing currently, only time will tell the full impact the changes in regulations will have on the medical and drug industry .
Britain’s departure from the EU will mean that regulatory bodies in this country will have to establish new systems to govern safety of devices. In the current EU system, approval means products "can be marketed if they perform 'as intended' and are likely to be safe".